Literature DB >> 22634070

Injectable system for spatio-temporally controlled delivery of hypoxia-induced angiogenic signalling.

E Hadjipanayi1, U Cheema, U Hopfner, A Bauer, H G Machens, A F Schilling.   

Abstract

While chronically ischaemic tissues are continuously exposed to hypoxia, the primary angiogenic stimulus, they fail to appropriately respond to it, as hypoxia-regulated angiogenic factor production gradually undergoes down-regulation, thus hindering adaptive angiogenesis. We have previously reported on two strategies for delivering on demand hypoxia-induced signalling (HIS) in vivo, namely, implanting living or non-viable hypoxic cell-matrix depots that actively produce factors or act as carriers of factors trapped within the matrix during in vitro pre-conditioning, respectively. This study aims to improve this approach through the development of a novel, injectable system for delivering cell-free matrix HIS-carriers. 3D spiral collagen constructs, comprising an inner cellular and outer acellular compartment, were cultured under hypoxia (5% O₂). Cell-produced angiogenic factors (e.g. VEGF, FGF, PLGF, IL-8) were trapped within the nano-porous matrix of the acellular compartment as they radially diffused through it. The acellular matrix was mechanically fragmented into micro-fractions and added into a low temperature (5 °C) thermo-responsive type I collagen solution, which underwent a collagen concentration-dependent solution-to-gel phase transition at 37 °C. Levels of VEGF and IL-8, delivered from matrix fractions into media by diffusion through collagen sol-gel, were up-regulated by day 4 of hypoxic culture, peaked at day 8, and gradually declined towards the baseline by day 20, while FGF levels were stable over this period. Factors captured within matrix fractions were bioactive after 3 months freeze storage, as shown by their ability to induce tubule formation in an in vitro angiogenesis assay. This system provides a minimally invasive, and repeatable, method for localised delivery of time-specific, cell-free HIS factor mixtures, as a tool for physiological induction of spatio-temporally controlled angiogenesis.
Copyright © 2012. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22634070     DOI: 10.1016/j.jconrel.2012.04.048

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  8 in total

1.  Design of Injectable Materials to Improve Stem Cell Transplantation.

Authors:  Laura M Marquardt; Sarah C Heilshorn
Journal:  Curr Stem Cell Rep       Date:  2016-07-01

Review 2.  Controlled protein delivery in the generation of microvascular networks.

Authors:  Jillian W Andrejecsk; William G Chang; Jordan S Pober; W Mark Saltzman
Journal:  Drug Deliv Transl Res       Date:  2015-04       Impact factor: 4.617

3.  Biodegradable poly (lactic acid-co-glycolic acid) scaffolds as carriers for genetically-modified fibroblasts.

Authors:  Tatjana Perisic; Ziyang Zhang; Peter Foehr; Ursula Hopfner; Kathrin Klutz; Rainer H Burgkart; Alexei Slobodianski; Moritz Goeldner; Hans-Günther Machens; Arndt F Schilling
Journal:  PLoS One       Date:  2017-04-05       Impact factor: 3.240

4.  Hypoxia Preconditioned Serum (HPS) Promotes Osteoblast Proliferation, Migration and Matrix Deposition.

Authors:  Jun Jiang; Lynn Röper; Sarah Alageel; Ulf Dornseifer; Arndt F Schilling; Ektoras Hadjipanayi; Hans-Günther Machens; Philipp Moog
Journal:  Biomedicines       Date:  2022-07-07

Review 5.  Stimuli-Responsive Delivery of Growth Factors for Tissue Engineering.

Authors:  Moyuan Qu; Xing Jiang; Xingwu Zhou; Canran Wang; Qingzhi Wu; Li Ren; Jixiang Zhu; Songsong Zhu; Peyton Tebon; Wujin Sun; Ali Khademhosseini
Journal:  Adv Healthc Mater       Date:  2020-03-03       Impact factor: 9.933

Review 6.  Hypoxia-based strategies for angiogenic induction: the dawn of a new era for ischemia therapy and tissue regeneration.

Authors:  Ektoras Hadjipanayi; Arndt F Schilling
Journal:  Organogenesis       Date:  2013-08-08       Impact factor: 2.500

7.  Regeneration through autologous hypoxia preconditioned plasma.

Authors:  Ektoras Hadjipanayi; Arndt F Schilling
Journal:  Organogenesis       Date:  2014-05-15       Impact factor: 2.500

8.  Hypoxia Preconditioned Serum (HPS)-Hydrogel Can Accelerate Dermal Wound Healing in Mice-An In Vivo Pilot Study.

Authors:  Jun Jiang; Ursula Kraneburg; Ulf Dornseifer; Arndt F Schilling; Ektoras Hadjipanayi; Hans-Günther Machens; Philipp Moog
Journal:  Biomedicines       Date:  2022-01-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.